Cronos (NASDAQ: CRON ) reported increasing revenues and net income for Q1-2025. Its international and domestic sales have increased. The company’s stock is up 25% over the last month. It is up 6.5% since I covered it last March onWelcome to the home of The Cannabis Report: a monthly report on the cannabis industry. I am an analyst and consultant in the cannabis industry. I have contributed to High Times Magazine. I currently have a book out, Cannabis in the Ancient Greek and Roman World. I am most intereste ...